Clinical Research Coordinator II - VANGUARD (MAMC)

Federallabs; Joint Base Lewis-McChord (WA); Presencial; USD 54.000 - 86.000; Jornada completa

Descripción de la vacante

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is seeking an experienced Clinical Research Coordinator II for the Murtha Cancer Center at Madigan Army Medical Center, Joint Base Lewis-McChord, WA, onsite.

You will support DoD/CSRN Vanguard Study involving multi-cancer detection, handling patient recruitment, consent, specimen processing, and regulatory tasks to advance military medical research.

Formación

• Experience coordinating clinical research activities.
• Knowledge of consent processes and regulatory documentation.
• Experience with specimen handling and shipping.

Responsabilidades

• Recruit and consent study participants.
• Process and ship specimens per protocol.
• Maintain study documentation and regulatory records.
• Support Vanguard Study implementation within CSRN.

Conocimientos

Clinical research coordination

Patient recruitment

Informed consent

Specimen processing

Regulatory management

Descripción del empleo

Join the HJF Team!

The Murtha Cancer Center is seeking an experienced Clinical Research Coordinator II. This position will be in support of the John P. Murtha Cancer Center at:Madigan Army Medical Center, Joint Base Lewis-McChord, WA, onsite.

The Murtha Cancer Center is a modern, patient-centric, tri-service military healthcare facility. Its comprehensive core of military and civilian oncologists and other cancer-trained clinicians and researchers provide multidisciplinary cancer-care delivery and patient-family support services. Our Cancer Center, the only DoD Cancer Center of Excellence within the Military Health System, offers its patients access to innovative cancer diagnostic and treatment technologies.

The successful candidate will play a crucial role in clinical research activities, including patient recruitment, consent processes, specimen processing and shipping, study documentation and basic regulatory management for a study involving Multi-Cancer Detection Tests. The Department of Defense (DoD), represented by USU/MCCRP, is participating in the NCI Cancer Screening Research Network (CSRN). The CSRN consists of seven civilianhealthcare systems, the Department of Veterans Affairs and the DoD. The first study the CSRN is undertaking is a pilot study, known as the Vanguard Study (on Multi-Cancer Detection), which will enroll 24,000 total volunteers over four years. Multi-Cancer Detection tests claim to screen for several types of cancers using only a blood sample. The study will address if detection with this method leads to better outcomes and more lives saved. The results of the Vanguard study will inform the design of a larger randomized controlled trial involving about 225,000 people.

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is a nonprofit organization dedicated to advancing military medicine. We serve military, medical, academic and government clients by administering, managing, and supporting preeminent scientific programs that benefit members of the armed forces and civilians alike. Since its founding in 1983, HJF has served as a vital link between the military medical community and its federal and private partners. HJF's support and administrative capabilities allow military medical researchers and clinicians to maintain their scientific focus and accomplish their research goals.